Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
Status:
Recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
Under placebo control, the investigators intend to evaluate the effectiveness and safety of
anti-inflammatory therapy and/or targeted drug therapy for early treatment of patients with
pulmonary arterial hypertension.